Abstract

Folates have been shown to play a crucial role for proper development of the embryo as folate deficiency has been associated with reduced developmental capacity such as increased risk of fetal neural tube defects and spontanous abortion. Transcripts encoding the reduced folate carrier RFC1 (SLC19A1 protein) and the high-affinity folate receptor FOLR1 are expressed in oocytes and preimplantation embryos, respectively. In this study, we observed maternally contributed FOLR1 protein during mouse and human ovarian follicle development, and 2-cell mouse embryos. In mice, FOLR1 was highly enriched in oocytes from primary, secondary and tertiary follicles, and in the surrounding granulosa cells. Interestingly, during human follicle development, we noted a high and specific presence of FOLR1 in oocytes from primary and intermediate follicles, but not in the granulosa cells. The distribution of FOLR1 in follicles was noted as membrane-enriched but also seen in the cytoplasm in oocytes and granulosa cells. In 2-cell embryos, FOLR1-eGFP fusion protein was detected as cytoplasmic and membrane-associated dense structures, resembling the distribution pattern observed in ovarian follicle development. Knock-down of Folr1 mRNA function was accomplished by microinjection of short interference (si)RNA targeting Folr1, into mouse pronuclear zygotes. This revealed a reduced capacity of Folr1 siRNA-treated embryos to develop to blastocyst compared to the siRNA-scrambled control group, indicating that maternally contributed protein and zygotic transcripts sustain embryonic development combined. In summary, maternally contributed FOLR1 protein appears to maintain ovarian functions, and contribute to preimplantation development combined with embryonically synthesized FOLR1.

Highlights

  • It is well-established that folates are important for the development of the embryo

  • We first wished to analyse if the Folr1 transcript would be expressed in germinal vesicle (GV) and metaphase II (MII) oocytes as well as during preimplantation development, and if the transcript would be expressed solely from the zygotic genome

  • The qPCR analysis revealed that Folr1 was detectable at very low expression at the 2-cell stage, and its transcript gradually increased to the blastocyst stages (Figure 1)

Read more

Summary

Introduction

It is well-established that folates are important for the development of the embryo. Pregnant women are advised to take a dietary supplement of 400 mg folic acid per day from 12 weeks before conception and during the first trimester of pregnancy (Hibbard, 1964; Cawley et al, 2016). Folate deficiency has been associated with increasing the risk of neural tube defects (NTD). The identification of folate receptor autoantibodies in in women with recurrent NTD pregnancies might mechanistically explain how the embryo is deprived of folate (Rothenberg et al, 2004; Berrocal-Zaragoza et al, 2009; Sequeira et al, 2013). Folic acid supplementation in pregnancy may have beneficial effects on the neurodevelopment of children, such as cerebral folate deficiency syndrome and autism spectrum disorders (Desai et al, 2016), beyond its proven effect on NTDs (Blencowe et al, 2010; De-Regil et al, 2015; Gao et al, 2016)

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call